Philips' earnings growth supported by productivity, cost control, and AI-driven healthcare potential.

Philips continues to show earnings growth driven by productivity initiatives, strict cost discipline, and portfolio transformation. The company’s large installed base and proprietary healthcare data position it well to benefit from AI-enabled healthcare applications. Following a strong first quarter and a potential recovery in the European MedTech sector, there is optimism for further earnings growth and valuation expansion. Investors remain positive on Philips' prospects in the evolving healthcare market.